Gene · 9475
Papers3,801
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
661 to 680 of 3,801
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Ellagic Acid Triggers the Necrosis of Differentiated Human Enterocytes Exposed to 3-Nitro-Tyrosine: An MS-Based Proteomic Study. | Antioxidants (Basel) | 2022 | 36552693 | PubTator, text mining | PubMed |
| Axonal Regeneration: Underlying Molecular Mechanisms and Potential Therapeutic Targets. | Biomedicines | 2022 | 36551942 | PubTator, text mining | PubMed |
| Genetic Alterations and Deregulation of Hippo Pathway as a Pathogenetic Mechanism in Bone and Soft Tissue Sarcoma. | Cancers (Basel) | 2022 | 36551696 | PubTator, text mining | PubMed |
| Multiple pathways promote microtubule stabilization in senescent intestinal epithelial cells. | NPJ Aging | 2022 | 36526654 | PubTator, text mining | PubMed |
| Advances in Molecular Pathology of Obstructive Sleep Apnea. | Molecules | 2022 | 36500515 | PubTator, text mining | PubMed |
| Investigating the Anticancer Activity of G-Rh1 Using In Silico and In Vitro Studies (A549 Lung Cancer Cells). | Molecules | 2022 | 36500403 | PubTator, text mining | PubMed |
| Key Genetic Components of Fibrosis in Diabetic Nephropathy: An Updated Systematic Review and Meta-Analysis. | Int J Mol Sci | 2022 | 36499658 | PubTator, text mining | PubMed |
| Systems Biology in Chronic Heart Failure-Identification of Potential miRNA Regulators. | Int J Mol Sci | 2022 | 36499552 | PubTator, text mining | PubMed |
| Novel Dual AChE and ROCK2 Inhibitor Induces Neurogenesis via PTEN/AKT Pathway in Alzheimer's Disease Model. | Int J Mol Sci | 2022 | 36499116 | PubTator, text mining | PubMed |
| Immunogenic Death of Hepatocellular Carcinoma Cells in Mice Expressing Caspase-Resistant ROCK1 Is Not Replicated by ROCK Inhibitors. | Cancers (Basel) | 2022 | 36497425 | PubTator, text mining | PubMed |
| NPFFR2 Contributes to the Malignancy of Hepatocellular Carcinoma Development by Activating RhoA/YAP Signaling. | Cancers (Basel) | 2022 | 36497331 | PubTator, text mining | PubMed |
| OMICS Approaches Evaluating Keloid and Hypertrophic Scars. | Int J Inflam | 2022 | 36483731 | PubTator, text mining | PubMed |
| A novel signature based on CeRNA and immune status predicts prognostic risk and drug sensitivity in gastric cancer patients. | Front Immunol | 2022 | 36483555 | PubTator, text mining | PubMed |
| Current situation and progress of drugs for reducing intraocular pressure. | Ther Adv Chronic Dis | 2022 | 36479139 | PubTator, text mining | PubMed |
| Critical role of Rho proteins in myosin light chain di-phosphorylation during early phase of endothelial barrier disruption. | J Physiol Sci | 2022 | 36476233 | PubTator, text mining | PubMed |
| DGMP: Identifying Cancer Driver Genes by Jointing DGCN and MLP from Multi-omics Genomic Data. | Genomics Proteomics Bioinformatics | 2022 | 36464123 | PubTator, text mining | PubMed |
| Circ_0004104 participates in the regulation of ox-LDL-induced endothelial cells injury via miR-942-5p/ROCK2 axis. | BMC Cardiovasc Disord | 2022 | 36460954 | PubTator, text mining | PubMed |
| Overcoming the therapeutic resistance of hepatomas by targeting the tumor microenvironment. | Front Oncol | 2022 | 36457492 | PubTator, text mining | PubMed |
| Role of androgen receptor signaling pathway-related lncRNAs in the prognosis and immune infiltration of breast cancer. | Sci Rep | 2022 | 36450882 | PubTator, text mining | PubMed |
| Dissecting exosome inhibitors: therapeutic insights into small-molecule chemicals against cancer. | Exp Mol Med | 2022 | 36446847 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9475/papers?page=34